Concentrix (CNXC) Stock Forecast, Price Target & Predictions
CNXC Stock Forecast
Concentrix stock forecast is as follows: an average price target of $75.00 (represents a 38.99% upside from CNXC’s last price of $53.96) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
CNXC Price Target
The average price target for Concentrix (CNXC) is $75.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $85.00 to $70.00. This represents a potential 38.99% upside from CNXC's last price of $53.96.
CNXC Analyst Ratings
According to 4 Wall Street analysts, Concentrix's rating consensus is 'Buy'. The analyst rating breakdown for CNXC stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 2 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Concentrix Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 02, 2024 | David Koning | Robert W. Baird | $70.00 | $51.70 | 35.40% | 29.73% |
| Sep 26, 2024 | Vincent Colicchio | Barrington | $70.00 | $55.58 | 25.94% | 29.73% |
| Aug 28, 2024 | Ruplu Bhattacharya | Bank of America Securities | $85.00 | $74.81 | 13.61% | 57.52% |
| Apr 29, 2024 | Divya Goyal | Scotiabank | $85.00 | $56.86 | 49.49% | 57.52% |
| Jul 13, 2022 | Vincent Colicchio | Barrington | $183.00 | $126.90 | 44.21% | 239.14% |
The latest Concentrix stock forecast, released on Oct 02, 2024 by David Koning from Robert W. Baird, set a price target of $70.00, which represents a 35.40% increase from the stock price at the time of the forecast ($51.70), and a 29.73% increase from CNXC last price ($53.96).
Concentrix Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 4 |
| Avg Price Target | - | - | $77.50 |
| Last Closing Price | $53.96 | $53.96 | $53.96 |
| Upside/Downside | -100.00% | -100.00% | 43.62% |
In the current month, the average price target of Concentrix stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Concentrix's last price of $53.96. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 23, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Aug 28, 2024 | Citigroup | Neutral | Upgrade | |
| Aug 28, 2024 | Bank of America Securities | Neutral | Upgrade | |
| Apr 29, 2024 | Scotiabank | Outperform | Outperform | Hold |
Concentrix's last stock rating was published by Canaccord Genuity on Sep 23, 2024. The company gave CNXC a "Buy" rating, the same as its previous rate.
Concentrix Financial Forecast
Concentrix Revenue Forecast
| Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $2.23B | $1.63B | $1.61B | - | - | $1.58B | $1.57B | - | - | $1.40B | $1.37B | - | - |
| Avg Forecast | $2.50B | $2.44B | $2.43B | $2.42B | $2.45B | $2.37B | $2.36B | $2.37B | $2.44B | $2.38B | $2.35B | $2.38B | $2.20B | $1.64B | $1.66B | $1.63B | $1.69B | $1.59B | $1.57B | $1.53B | $1.46B | $1.38B | $1.36B | $1.30B | $1.24B |
| High Forecast | $2.50B | $2.44B | $2.43B | $2.43B | $2.46B | $2.37B | $2.37B | $2.37B | $2.44B | $2.38B | $2.35B | $2.38B | $2.21B | $1.64B | $1.66B | $1.63B | $2.02B | $1.60B | $1.58B | $1.54B | $1.47B | $1.39B | $1.36B | $1.30B | $1.24B |
| Low Forecast | $2.49B | $2.43B | $2.42B | $2.42B | $2.45B | $2.37B | $2.36B | $2.36B | $2.44B | $2.38B | $2.35B | $2.38B | $2.20B | $1.64B | $1.65B | $1.63B | $1.35B | $1.58B | $1.57B | $1.53B | $1.46B | $1.38B | $1.35B | $1.29B | $1.24B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.00% | 0.97% | - | - | 0.99% | 1.00% | - | - | 1.01% | 1.01% | - | - |
Concentrix's average Quarter revenue forecast for Mar 24 based on 1 analysts is $2.38B, with a low forecast of $2.38B, and a high forecast of $2.38B. CNXC's average Quarter revenue forecast represents a 6.62% increase compared to the company's last Quarter revenue of $2.23B (Nov 23).
Concentrix EBITDA Forecast
| Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $180.45M | $156.10M | $153.18M | - | - | $169.63M | $159.46M | - | - | $224.38M | $202.59M | - | - |
| Avg Forecast | $312.11M | $304.83M | $303.48M | $303.19M | $306.81M | $296.41M | $295.62M | $295.89M | $305.25M | $297.81M | $293.66M | $262.99M | $275.52M | $205.25M | $207.20M | $239.08M | $224.16M | $173.48M | $171.59M | $217.35M | $159.44M | $150.79M | $148.26M | $184.48M | $192.39M |
| High Forecast | $312.46M | $305.17M | $303.82M | $303.52M | $307.15M | $296.73M | $295.95M | $296.21M | $305.58M | $297.89M | $293.66M | $315.59M | $275.82M | $205.48M | $207.43M | $286.90M | $268.99M | $174.13M | $172.24M | $260.82M | $160.04M | $151.36M | $148.81M | $221.38M | $230.87M |
| Low Forecast | $311.77M | $304.50M | $303.15M | $302.86M | $306.48M | $296.08M | $295.30M | $295.56M | $304.91M | $297.73M | $293.66M | $210.39M | $275.22M | $205.02M | $206.97M | $191.27M | $179.32M | $172.88M | $171.00M | $173.88M | $158.89M | $150.28M | $147.75M | $147.58M | $153.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.65% | 0.76% | 0.74% | - | - | 0.98% | 0.93% | - | - | 1.49% | 1.37% | - | - |
1 analysts predict CNXC's average Quarter EBITDA for Mar 24 to be $262.99M, with a high of $315.59M and a low of $210.39M. This is 45.74% upper than Concentrix's previous annual EBITDA (Nov 23) of $180.45M.
Concentrix Net Income Forecast
| Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $69.49M | $77.64M | $78.85M | - | - | $106.69M | $113.14M | - | - | $109.75M | $82.90M | - | - |
| Avg Forecast | $215.15M | $204.61M | $196.72M | $188.62M | $204.70M | $184.46M | $176.52M | $167.71M | $193.58M | $186.83M | $168.98M | $126.54M | $197.68M | $183.10M | $176.97M | $115.03M | $122.41M | $192.30M | $182.59M | $104.58M | $175.47M | $145.25M | $146.76M | $81.23M | $63.35M |
| High Forecast | $215.46M | $204.90M | $197.00M | $188.89M | $204.99M | $184.72M | $176.78M | $167.95M | $195.51M | $187.66M | $168.99M | $151.84M | $198.32M | $183.36M | $177.23M | $138.04M | $146.90M | $193.24M | $183.48M | $125.49M | $176.32M | $145.96M | $147.48M | $97.48M | $76.02M |
| Low Forecast | $214.85M | $204.31M | $196.44M | $188.35M | $204.41M | $184.20M | $176.27M | $167.47M | $191.00M | $186.00M | $168.97M | $101.23M | $197.04M | $182.84M | $176.72M | $92.03M | $97.93M | $191.45M | $181.78M | $83.66M | $174.69M | $144.60M | $146.11M | $64.99M | $50.68M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.35% | 0.42% | 0.45% | - | - | 0.55% | 0.62% | - | - | 0.76% | 0.56% | - | - |
Concentrix's average Quarter net income forecast for Mar 24 is $126.54M, with a range of $101.23M to $151.84M. CNXC's average Quarter net income forecast represents a 82.10% increase compared to the company's last Quarter net income of $69.49M (Nov 23).
Concentrix SG&A Forecast
| Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $642.41M | $431.43M | $417.66M | - | - | $409.30M | $402.00M | - | - | $329.96M | $354.50M | - | - |
| Avg Forecast | $677.91M | $662.10M | $659.17M | $658.53M | $666.40M | $643.80M | $642.09M | $642.67M | $663.00M | $646.84M | $637.82M | $447.97M | $598.43M | $445.80M | $450.04M | $407.24M | $356.53M | $435.89M | $431.16M | $370.22M | $400.63M | $378.89M | $372.52M | $321.20M | $331.76M |
| High Forecast | $678.66M | $662.83M | $659.89M | $659.25M | $667.13M | $644.51M | $642.80M | $643.37M | $663.73M | $647.02M | $637.82M | $537.56M | $599.09M | $446.29M | $450.54M | $488.69M | $427.83M | $437.53M | $432.77M | $444.27M | $402.13M | $380.31M | $373.91M | $385.44M | $398.11M |
| Low Forecast | $677.17M | $661.38M | $658.45M | $657.81M | $665.67M | $643.10M | $641.39M | $641.96M | $662.27M | $646.67M | $637.82M | $358.37M | $597.78M | $445.32M | $449.55M | $325.79M | $285.22M | $434.40M | $429.68M | $296.18M | $399.25M | $377.59M | $371.24M | $256.96M | $265.41M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 0.97% | 0.93% | - | - | 0.94% | 0.93% | - | - | 0.87% | 0.95% | - | - |
Concentrix's average Quarter SG&A projection for Mar 24 is $447.97M, based on 1 Wall Street analysts, with a range of $358.37M to $537.56M. The forecast indicates a -30.27% fall compared to CNXC last annual SG&A of $642.41M (Nov 23).
Concentrix EPS Forecast
| Nov 26 | Aug 26 | May 26 | Mar 26 | Nov 25 | Aug 25 | May 25 | Mar 25 | Nov 24 | Aug 24 | May 24 | Mar 24 | Nov 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $1.12 | $1.50 | $1.51 | - | - | $2.05 | $2.16 | - | - | $2.10 | $1.59 | - | - |
| Avg Forecast | $3.34 | $3.18 | $3.06 | $2.93 | $3.18 | $2.87 | $2.74 | $2.61 | $3.01 | $2.90 | $2.63 | $2.58 | $3.07 | $2.85 | $2.75 | $2.60 | $1.95 | $2.97 | $2.82 | $2.70 | $2.71 | $2.24 | $2.27 | $2.11 | $2.03 |
| High Forecast | $3.35 | $3.18 | $3.06 | $2.94 | $3.19 | $2.87 | $2.75 | $2.61 | $3.04 | $2.92 | $2.63 | $2.58 | $3.08 | $2.85 | $2.75 | $2.60 | $2.00 | $2.98 | $2.83 | $2.71 | $2.72 | $2.25 | $2.28 | $2.12 | $2.04 |
| Low Forecast | $3.34 | $3.17 | $3.05 | $2.93 | $3.18 | $2.86 | $2.74 | $2.60 | $2.97 | $2.89 | $2.63 | $2.58 | $3.06 | $2.84 | $2.75 | $2.59 | $1.89 | $2.96 | $2.81 | $2.69 | $2.70 | $2.23 | $2.26 | $2.10 | $2.02 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.36% | 0.53% | 0.55% | - | - | 0.69% | 0.77% | - | - | 0.94% | 0.70% | - | - |
According to 1 Wall Street analysts, Concentrix's projected average Quarter EPS for Mar 24 is $2.58, with a low estimate of $2.58 and a high estimate of $2.58. This represents a 130.30% increase compared to CNXC previous annual EPS of $1.12 (Nov 23).
Concentrix Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CLVT | Clarivate | $5.52 | $14.33 | 159.60% | Buy |
| PSN | Parsons | $79.85 | $118.00 | 47.78% | Buy |
| CNXC | Concentrix | $53.96 | $75.00 | 38.99% | Buy |
| CACI | CACI | $385.71 | $521.00 | 35.08% | Buy |
| LDOS | Leidos | $140.27 | $187.33 | 33.55% | Buy |
| SAIC | Science Applications | $106.62 | $135.25 | 26.85% | Buy |
| CDW | CDW | $195.53 | $245.00 | 25.30% | Buy |
| GLOB | Globant | $208.12 | $241.43 | 16.01% | Buy |
| ACN | Accenture | $374.42 | $382.14 | 2.06% | Buy |
| CTSH | Cognizant Technology Solutions | $81.19 | $82.29 | 1.35% | Hold |
| ASGN | ASGN | $93.22 | $88.00 | -5.60% | Buy |
| WNS | WNS | $62.42 | $57.50 | -7.88% | Buy |
| G | Genpact | $47.54 | $43.67 | -8.14% | Hold |
| EXLS | ExlService | $49.90 | $39.00 | -21.84% | Buy |